WLSI Stock Overview
Wellstar International, Inc. does not have significant operations.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Wellstar International, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | -90.00% |
| 1 Year Change | 0% |
| 3 Year Change | -99.33% |
| 5 Year Change | -99.00% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| WLSI | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 1.8% | 1.2% |
| 1Y | 0% | -0.5% | 24.9% |
Return vs Industry: WLSI matched the US Medical Equipment industry which returned -0.7% over the past year.
Return vs Market: WLSI underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| WLSI volatility | |
|---|---|
| WLSI Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: WLSI's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine WLSI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | n/a | John Antonio | n/a |
Wellstar International, Inc. does not have significant operations. Previously, the company, through its subsidiary, Trillennium Medical Imaging, Inc., engaged in developing and licensing advanced thermal imaging technology in the consumer health care markets. Its technology enabled a diagnostic screening procedure for the early breast cancer detection; the differential diagnosis of pain dysfunctions, such as reflex sympathetic dystrophy, neuromuscular skeletal syndromes, and neurological disorders; and the detection of pressure ulcers, deep tissue injuries, and bed sores, as well as orthopedic applications.
Wellstar International, Inc. Fundamentals Summary
| WLSI fundamental statistics | |
|---|---|
| Market cap | US$9.01k |
| Earnings (TTM) | -US$12.59m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs WLSI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WLSI income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$12.59m |
| Earnings | -US$12.59m |
Last Reported Earnings
Oct 31, 2010
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did WLSI perform over the long term?
See historical performance and comparison